News for Merit Medical Systems, Inc. (MMSI)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. ( MMSI), a global leader of healthcare technology, announced that Chairman

On March 3, 2025, Stephen Evans, a Director at Merit Medical Systems Inc (MMSI), sold 5,000 shares of the company, according to a SEC Filing. Following this tra

Merit Medical Systems Inc's robust product portfolio and market presence underscore its competitive strengths.Recent strategic acquisitions have expanded the c

Total Revenue: $355.2 million, up 9% year-over-year on a GAAP basis and 10% on a constant currency basis.Non-GAAP Operating Margin: 19.6% of sales, up approxim

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsFred Lampropoulos - Founder,...

Fourth Quarter Highlights”  Reported revenue of $355.2 million, up 9.4%Constant currency revenue* and constant currency revenue, organic* up 10.1% and u

Fresenius Medical, Masimo, Merit Medical Systems and Inogen are included in this Analyst Blog.

Merit Medical Systems Inc (MMSI) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for Q4 2024 revenue is $351.35 million, and the

Merit Medical Systems (MMSI) Q4 earnings out Feb 25! Consensus EPS: $0.83 (+2.5% Y/Y), Revenue: $351.54M (+8.3%).

On December 31, 2024, Aristotle Capital Boston, LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in 1-800-Flowers.com Inc (FLWS) by 215,

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

U.S. equity indices generated modest returns in the fourth quarter of 2024, and closed out the full year with double digit returns for the second year in a row.

In this article, we explore the latest trends in the financial market and provide insights on investment strategies and managing personal finances.

Merit Medical Systems' stock is up 40% from last spring's lows, driven by strong Q3 results and positive analyst sentiment. Explore more details here.

Merit Medical Systems (MMSI) has received FDA approval for its WRAPSODY Cell-Impermeable Endoprosthesis device for the treatment of dialysis patients. Read more here.

Merit Medical Systems Inc (MMSI), a prominent global healthcare technology company, has announced the FDA's premarket approval of its WRAPSODY® Cell-Impermeabl

**media[497866]**

In the current market session, Merit Medical Systems Inc. MMSI share price is at $97.14, after a 0.01% increase. Moreover, over the past month, the stock decrea...